Human embryos; a collapsing market?

27 May 2019
by: 
IGIR in Law

When compared to other countries, European researchers in the field of human embryonic stem cells maybe at a disadvantage. Because of the morality clause in the European Patent Convention, the EPO does not grant patents on human embryonic stem cell research.